Remediation Sciences

Dr. Mark MacMillin is a licensed psychologist and professor specializing in helping individuals reflect on their personal narratives, fostering connections between their life stories and successful living. His experience in psychology and storytelling has led him to write novels that explore navigating challenging relationships through character-driven narratives. In addition to his practice, Dr. MacMillin speaks on various psychological topics, emphasizing secure attachment, mindfulness, forgiveness, and the importance of processing grief and trauma. He believes that personal growth and patience are essential for the success of intimate relationships and for cultivating one's own narrative. Generated from the website

What is Defend The Bay Defend The Bay is a non-profit Newport Beach-based environmental organization dedicated to the protection of Newport Bay and coastal waters in Orange County. Founded in 1995, Defend The Bay employs a unique mix of education, science, and law as tools to preserve and protect Orange County's heritage and crown environmental jewels. Thousands of supporters make it possible for Defend The Bay to successfully litigate and advocate on behalf of Newport Bay and coastal waters. Defend The Bay is fiercely independent-we take NO contributions from sewage plants, big developers, or others whose interests are different than ours. We are scrupulous professionals, working with some of the best-trained and most experienced scientists and lawyers in the country. Come to a local meeting or hearing. We're the ones wearing suits.

CureDuchenne is a nonprofit organization based in Newport Beach, California, dedicated to curing Duchenne muscular dystrophy (DMD). Through an innovative venture philanthropy model, they fund groundbreaking research, enhance early diagnosis, and improve access to treatments while providing vital educational resources and support for families affected by the disease. Founded by Debra Miller, whose personal journey with DMD fuels the organization's mission, CureDuchenne has significantly contributed to the uptick in life expectancy for those with DMD and facilitated numerous critical clinical trials. Their efforts have attracted over $3 billion in follow-on funding, showcasing a commitment to making meaningful progress within the muscle disease community. Generated from the website